News

Lyvgen, a biopharmaceutical company focused on developing innovative immuno-oncology therapeutics, announces that it has entered into a clinical trial collaboration agreement with a…
Read More...

FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark site of FUJIFILM Diosynth Biotechnologies, a leading contract…
Read More...

Evox Therapeutics Ltd announced a research collaboration and license agreement with Eli Lilly and Company to leverage Evox’s proprietary DeliverEX platform to develop and deliver RNA…
Read More...

Oxford Biomedica plc announced that it has signed a Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organisation established to…
Read More...

Innovent Biologics, Inc. announced a strategic research and development collaboration with Roche covering multiple cell therapies and bispecific antibodies. The collaboration will…
Read More...

Alphamab Oncology a clinical stage biopharmaceutical company focusing on innovative biologics medicine for oncology, and Sanofi, a global biopharmaceutical leader, announced today that…
Read More...

HitGen announced that it has entered into a drug discovery research collaboration with Evotec SE to identify small molecule leads against targets of interest to Evotec SE in the field…
Read More...

AbbVie, Harbour BioMed (HBM), Utrecht University (UU) and Erasmus Medical Center (EMC) announced they have entered into a collaboration to develop a novel antibody therapeutic to…
Read More...

UCB announced the acquisition of Engage Therapeutics, Inc. (Summit, N.J. (U.S.)), a clinical-stage pharmaceutical company developing Staccato Alprazolam for the rapid termination of an…
Read More...

AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that it will partner with Novavax, Inc. a late-stage biotechnology…
Read More...

AstraZeneca will collaborate with Accent Therapeutics to discover, develop and commercialise transformative therapeutics targeting RNA-modifying proteins (RMPs) for the treatment of…
Read More...

The European Commission (EC) has approved Sarclisa (isatuximab) in combination with pomalidomide and dexamethasone (pom-dex) for the treatment of adult patients with relapsed and…
Read More...

Intravacc and EpiVax announce that they have entered into a collaboration agreement to further progress an novel vaccine against COVID-19, based on Intravacc’s proprietary Outer…
Read More...

AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the purchase of a state-of-the-art commercial manufacturing facility in…
Read More...

Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development today announced an extension of their ongoing collaboration with Infectious Disease Research…
Read More...

-Memo Therapeutics AG (“MTx”), an innovator in the field of antibody discovery and immune repertoire analysis,  announces that it has identified several SARS-CoV-2-specific…
Read More...

Study in California utilizing IVIG as investigational coronavirus treatment for adults experiencing respiratory failure Following positive preliminary data, Octapharma USA is…
Read More...

Tetraphase Pharmaceuticals, Inc. announced that it has entered into a definitive merger agreement with Melinta Therapeutics, Inc. (“Melinta”), pursuant to which Melinta would acquire…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced new data from two Phase 3 clinical trials, DISCOVER-1 and DISCOVER-2, which showed that TREMFYA (guselkumab)…
Read More...

Pierre Fabre announced that the European Commission (EC) has approved BRAFTOVI (encorafenib) in combination with cetuximab (marketed as Erbitux) for the treatment of adult patients with…
Read More...